Skip to main content

Inogen, Inc. (INGN)

NASDAQ: INGN · IEX Real-Time Price · USD
33.08 0.69 (2.13%)
Dec 8, 2021 4:00 PM EST - Market closed
Market Cap751.71M
Revenue (ttm)355.58M
Net Income (ttm)11.42M
Shares Out22.72M
EPS (ttm)0.50
PE Ratio65.77
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume121,154
Open32.35
Previous Close32.39
Day's Range31.86 - 33.52
52-Week Range29.28 - 82.35
Beta0.94
AnalystsHold
Price Target42.33 (+28.0%)
Earnings DateNov 4, 2021

About INGN

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrat...

IndustryHealth Care Equipment & Supplies
IPO DateFeb 14, 2014
CEOScott Wilkinson
Employees938
Stock ExchangeNASDAQ
Ticker SymbolINGN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for Inogen stock is "Hold." The 12-month stock price forecast is 42.33, which is an increase of 27.96% from the latest price.

Price Target
$42.33
(27.96% upside)
Analyst Consensus: Hold

News

Inogen (INGN) Earnings and Revenues Surpass Estimates in Q3

Inogen's (INGN) third-quarter results benefit from higher revenues across its segments.

1 month ago - Zacks Investment Research

Inogen (INGN) Q3 Earnings and Revenues Surpass Estimates

Inogen (INGN) delivered earnings and revenue surprises of 282.76% and 9.04%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Inogen Announces Third Quarter 2021 Financial Results

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for ...

1 month ago - Business Wire

Inogen Announces Participation in the Stifel Virtual Healthcare Conference

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's ma...

1 month ago - Business Wire

Inogen to Announce Third Quarter 2021 Financial Results on November 4, 2021

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third ...

1 month ago - Business Wire

Inogen Appoints Stanislav Glezer as Chief Technology Officer

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), (“Inogen” or “the Company”), a medical technology company offering innovative respiratory products for use in the homecare setting, today an...

1 month ago - Business Wire

Here's Why You Should Retain Inogen (INGN) Stock For Now

Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.

2 months ago - Zacks Investment Research

Inogen Strengthens Commercial Capabilities Through New Ashfield Relationship

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), (“Inogen” or “the Company”), a medical technology company offering innovative respiratory products for use in the homecare setting, today an...

2 months ago - Business Wire

Inogen (INGN) Stock Loses 26.7% In Spite of Q2 Earnings Beat

Inogen's (INGN) second-quarter results benefit from higher revenues across its segments.

4 months ago - Zacks Investment Research

Inogen Stock Plunges As Supply Chain Constraints Pile Up To Hit 2H FY21; Analysts Downgrade Stock

Inogen Inc (NASDAQ: INGN) reported Q2 revenue of $101.6 million, +41.7% Y/Y, beating the consensus of $88.75 million. The sales growth was driven primarily due to strong consumer demand, improved averag...

4 months ago - Benzinga

Inogen (INGN) Q2 Earnings and Revenues Beat Estimates

Inogen (INGN) delivered earnings and revenue surprises of 269.23% and 15.22%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Inogen: Q2 Earnings Insights

Shares of Inogen (NASDAQ:INGN) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 83.33% over the past year to $0.22, which beat the estim...

4 months ago - Benzinga

Inogen Announces Second Quarter 2021 Financial Results

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for ...

4 months ago - Business Wire

Earnings Preview: Inogen (INGN) Q2 Earnings Expected to Decline

Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

Inogen to Announce Second Quarter 2021 Financial Results on August 4, 2021

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second...

4 months ago - Business Wire

Inogen (INGN) Hits New 52-Week High: What's Driving It?

Investors are optimistic about Inogen's (INGN) direct-to-customer business model and a strong product portfolio.

4 months ago - Zacks Investment Research

Top Ranked Momentum Stocks to Buy for June 29th

Top Ranked Momentum Stocks to Buy for June 29th

Other symbols:AMNCMRESWBI
5 months ago - Zacks Investment Research

Here's Why You Should Add Inogen (INGN) to Your Portfolio

Investors continue to be optimistic about Inogen (INGN) on its direct-to-customer business model and a strong product portfolio.

5 months ago - Zacks Investment Research

Inogen Announces Appointment of General Counsel

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Dir...

5 months ago - Business Wire

Inogen Announces Appointment of Chief Medical Officer

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Dir...

6 months ago - Business Wire

Inogen (INGN) Down 11.5% Since Last Earnings Report: Can It Rebound?

Inogen (INGN) reported earnings 30 days ago. What's next for the stock?

6 months ago - Zacks Investment Research

Inogen Strengthens Board of Directors with Addition of Elizabeth Mora

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Elizabeth (Beth)...

6 months ago - Business Wire

Inogen Announces Participation in the 41st Annual William Blair Virtual Growth Stock Conference

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's ma...

6 months ago - Business Wire

Inogen (INGN) Q1 Loss Narrower Than Expected, Revenues Beat

Inogen (INGN) gains traction from revenue growth within its Rental segment in Q1.

7 months ago - Zacks Investment Research

Inogen (INGN) Reports Q1 Loss, Tops Revenue Estimates

Inogen (INGN) delivered earnings and revenue surprises of 89.29% and 8.44%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

7 months ago - Zacks Investment Research